Patent details

91167 Product Name: Bevacizumab tel que présent dans le produit AVASTIN approuvé par l'AEEM, comprenant les différentes formes et modifications post-traductionnelles du Bevacizumab qui y est présent, ainsi que les variantes immunologiques et immunochimiques de ceux-ci (AVASTIN®)

Basic Information

Publication number:
91167
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP030041990
Legal Status:
Expired
Application number:
91167
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
25/04/2017
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
16/11/2018
SPC Extension Rejection Date:

Marketing Authorization

1

Marketing Authorization Number:
Autorisation no: 56922 Index .07.16.1
Marketing Authorization Type:
Marketing Authorization Date:
16/12/2004
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Switzerland (CH)

2

Marketing Authorization Number:
EU/1/04/001-002
Marketing Authorization Type:
Marketing Authorization Date:
12/01/2005
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
20/04/2005
First Marketing Authorization date:
16/12/2004
Grant date:
20/06/2005
Activation date:
03/04/2018
Publication date:
20/06/2005
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
16/12/2019
SPC Extension Expiration:
16/06/2020
Rejection date:
Withdrawal date:

Owner

From:
20/04/2005
 
 

Name:
GENENTECH INC.
Address:
1 DNA Way, South San Francisco California 94080, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/04/2005
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Presta Leonard G.
Address:
United States (US)

2

Name:
Wells James A.
Address:
United States (US)

3

Name:
Baca Manuel, The Walter&Eliza Hall Inst. of. Med.
Address:
Australia (AU)

4

Name:
Chen Yvonne Man-Yee
Address:
United States (US)

5

Name:
Lowman Henry B.
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPCX2
Bulletin edition number:
2018/13
Publication date:
13/12/2018
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2018/06
Publication date:
22/05/2018
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
15/03/2019
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
25/04/2017 Application Form 4
31/01/2018 Incoming Correspondence (Post) 1
25/04/2017 General Document 2
25/04/2017 General Document 72
03/05/2017 General Document 5
03/05/2017 General Document 13
16/11/2018 Outgoing Correspondence 1
02/05/2017 FNET_DC_FRONTPAGE 1
31/01/2018 General Document 4
03/05/2017 General Document 5
16/11/2018 Publication 1
03/05/2017 General Document 72
16/11/2018 Certificate 1
03/05/2017 Incoming Correspondence (Post) 6
03/05/2017 General Document 3
25/04/2017 General Document 13
02/05/2017 Publication 1
02/05/2017 Outgoing Correspondence 1
25/04/2017 General Document 5